Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Opthea Limited (AU: OPT)

 
OPT Technical Analysis
4
As on 8th May 2025 OPT STOCK Price closed @ 0.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.57 & Strong Buy for SHORT-TERM with Stoploss of 0.50 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

OPTSTOCK Price

Open 0.60 Change Price %
High 0.60 1 Day 0.00 0.00
Low 0.60 1 Week 0.00 0.00
Close 0.60 1 Month 0.00 0.00
Volume N/A 1 Year 0.18 42.86
52 Week High 1.16 | 52 Week Low 0.34
 
AU Australia Most Active Stocks
LKY 0.04 33.33%
DTR 0.04 %
SYA 0.02 0.00%
PLS 1.48 -3.90%
WCN 0.03 0.00%
KNB 0.08 0.00%
GOR 3.30 -0.30%
TLS 4.59 0.66%
SIG 3.01 1.69%
CPH 0.01 0.00%
 
AU Australia Top Gainers Stocks
VR1 0.02 100.00%
APV 0.02 100.00%
NRX 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
PFE 0.02 100.00%
 
AU Australia Top Losers Stocks
SHP 0.00 -100.00%
SHP 0.00 -100.00%
SHP 0.00 -100.00%
SHP 0.00 -100.00%
EM2 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
 
 
OPT
Daily Charts		 OPT
Intraday Charts		 Whats New @
Bazaartrend		 OPT
Free Analysis
 
OPT Important Levels Intraday
RESISTANCE0.60
RESISTANCE0.60
RESISTANCE0.60
RESISTANCE0.60
RESISTANCE0.60
RESISTANCE0.60
RESISTANCE0.60
RESISTANCE0.60
 
OPT Forecast May 2025
Share
4th UP Forecast1.04
3rd UP Forecast0.9
2nd UP Forecast0.81
1st UP Forecast0.73
1st DOWN Forecast0.47
2nd DOWN Forecast0.39
3rd DOWN Forecast0.3
4th DOWN Forecast0.16
 
OPT Weekly Forecast
4th UP Forecast0.87
3rd UP Forecast0.78
2nd UP Forecast0.73
1st UP Forecast0.68
1st DOWN Forecast0.52
2nd DOWN Forecast0.47
3rd DOWN Forecast0.42
4th DOWN Forecast0.33
 
OPT Forecast2025
4th UP Forecast2.2
3rd UP Forecast1.69
2nd UP Forecast1.37
1st UP Forecast1.05
1st DOWN Forecast0.15
2nd DOWN Forecast-0.17
3rd DOWN Forecast-0.49
4th DOWN Forecast-1
 
 
OPT Other Details
Segment EQ
Market Capital 430521600.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
OPT Address
OPT
 
OPT Latest News
 
Your Comments and Response on Opthea Limited
 
OPT Business Profile
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME, as well as a first in class VEGF C/D inhibitors for treatment with VEGF A inhibitors for the treatment of wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Address: 650 Chapel Street, South Yarra, VIC, Australia, 3141
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service